MXPA04002709A - Derivados articonvulsivos utiles para el tratamiento del sindrome de extremidades inquietas y trastorno periodico del movimiento de extremidades. - Google Patents

Derivados articonvulsivos utiles para el tratamiento del sindrome de extremidades inquietas y trastorno periodico del movimiento de extremidades.

Info

Publication number
MXPA04002709A
MXPA04002709A MXPA04002709A MXPA04002709A MXPA04002709A MX PA04002709 A MXPA04002709 A MX PA04002709A MX PA04002709 A MXPA04002709 A MX PA04002709A MX PA04002709 A MXPA04002709 A MX PA04002709A MX PA04002709 A MXPA04002709 A MX PA04002709A
Authority
MX
Mexico
Prior art keywords
restless
syndrome
formula
topiramate
alkyl
Prior art date
Application number
MXPA04002709A
Other languages
English (en)
Spanish (es)
Inventor
S Abuzzahab Faruk
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of MXPA04002709A publication Critical patent/MXPA04002709A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
MXPA04002709A 2001-09-24 2002-09-23 Derivados articonvulsivos utiles para el tratamiento del sindrome de extremidades inquietas y trastorno periodico del movimiento de extremidades. MXPA04002709A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32444001P 2001-09-24 2001-09-24
PCT/US2002/030194 WO2003026676A1 (en) 2001-09-24 2002-09-23 Anticonvulsant derivatives useful for the treatment of restless limb syndrome and periodic limb movement disorder
US10/252,814 US20030092759A1 (en) 2001-09-24 2002-09-23 Anticonvulsant derivatives useful for the treatment of restless limb syndrome and periodic limb movement disorder

Publications (1)

Publication Number Publication Date
MXPA04002709A true MXPA04002709A (es) 2005-06-06

Family

ID=23263595

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04002709A MXPA04002709A (es) 2001-09-24 2002-09-23 Derivados articonvulsivos utiles para el tratamiento del sindrome de extremidades inquietas y trastorno periodico del movimiento de extremidades.

Country Status (8)

Country Link
US (1) US20030092759A1 (enExample)
EP (1) EP1429787A1 (enExample)
JP (1) JP2005512965A (enExample)
AU (1) AU2002336765B2 (enExample)
CA (1) CA2461539A1 (enExample)
MX (1) MXPA04002709A (enExample)
NZ (1) NZ531871A (enExample)
WO (1) WO2003026676A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
AU773642C (en) 1997-12-22 2006-04-06 Mundipharma Pty Limited Opioid agonist/antagonist combinations
CN1525851A (zh) 2001-05-11 2004-09-01 ������ҩ�����޹�˾ 抗滥用阿片样物质控释剂型
EP2316428A1 (en) 2002-04-05 2011-05-04 Euro-Celtique S.A. Matrix for sustained, invariant and independent release of active compounds
US20040115263A1 (en) * 2002-08-26 2004-06-17 Robertson David W. Use of bupropion for treating restless legs syndrome
MXPA06003043A (es) 2003-09-17 2006-05-31 Xenoport Inc Tratamiento o prevencion del sindrome piernas inquietas utilizando prodrogas de analogos gaba.
EP1604666A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
EP1604667A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the restless leg syndrome
AP2274A (en) * 2005-01-28 2011-08-19 Euro Celtiques Sa Alcohol resistant dosage forms.
EP1695700A1 (en) * 2005-02-28 2006-08-30 Euro-Celtique S.A. Dosage form containing oxycodone and naloxone
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
EP1813276A1 (en) * 2006-01-27 2007-08-01 Euro-Celtique S.A. Tamper resistant dosage forms
KR20130105935A (ko) * 2008-07-07 2013-09-26 유로-셀티큐 에스.에이. 요폐의 치료를 위한 아편유사제 길항제의 용도
US20110244057A1 (en) * 2008-09-25 2011-10-06 Ehrenberg Bruce L Combination therapies with topiramate for seizures, restless legs syndrome, and other neurological conditions
KR20140141727A (ko) 2009-03-10 2014-12-10 유로-셀티큐 에스.에이. 옥시코돈 및 날록손을 포함하는 즉시 방출 제약 조성물
US8690933B2 (en) * 2009-08-31 2014-04-08 Brigham Young University System and method for treating symptoms of restless legs syndrome
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
WO2015011189A1 (en) 2013-07-23 2015-01-29 Euro-Celtique S.A. A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1433306A (zh) * 1999-02-17 2003-07-30 奥索-麦克尼尔药品公司 用于治疗特发性震颤的抗惊厥衍生物
CA2369095C (en) * 1999-04-08 2006-07-25 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders
DE60016602T2 (de) * 1999-08-20 2005-11-03 Ortho-Mcneil Pharmaceutical, Inc. Zusammensetzung enthaltend ein tramadol und ein antikonvulsives arzneimittel
SE0000601D0 (sv) * 2000-02-24 2000-02-24 Jan Hedner Sätt att behandla och diagnostisera andningsstörningar i sömnen och medel för att utföra sättet

Also Published As

Publication number Publication date
CA2461539A1 (en) 2003-04-03
US20030092759A1 (en) 2003-05-15
AU2002336765B2 (en) 2007-12-20
WO2003026676A1 (en) 2003-04-03
JP2005512965A (ja) 2005-05-12
EP1429787A1 (en) 2004-06-23
NZ531871A (en) 2006-09-29

Similar Documents

Publication Publication Date Title
AU2002336765B2 (en) Anticonvulsant derivatives useful for the treatment of restless limb syndrome and periodic limb movement disorder
AU2002336765A1 (en) Anticonvulsant derivatives useful for the treatment of restless limb syndrome and periodic limb movement disorder
CA2417304A1 (en) Anticonvulsant derivatives useful for the treatment of depression
US20060122127A1 (en) Methods for reducing the side effects associated with mirtzapine treatment
PT1691811E (pt) Combinação de um sedativo e de um modulador de neurotransmissores e métodos para melhorar a qualidade do sono e tratamento da depressão
EA002554B1 (ru) Применение кабэрголина при лечении синдрома усталых ног
EP1809286A2 (en) Method for treatment of movement disorders
WO2022261263A1 (en) Methods of treating neuropsychiatric disorders
US12485100B2 (en) Treatment of menstrual cycle-induced symptoms
US20110244057A1 (en) Combination therapies with topiramate for seizures, restless legs syndrome, and other neurological conditions
CA3186900A1 (en) Compositions and methods for treating psychiatric disorders or symptoms thereof
US20140148465A1 (en) Compositions and Methods to Improve Treatment of Medical Conditions Using D-Cycloserine
JP2005508373A (ja) 抗痙攣剤誘導体およびカリウムを用いる共同療法を含んでなる感覚異常の処置および予防
EP2891491A1 (en) Use of (r)-phenylpiracetam for the treatment of sleep disorders
JP7185260B2 (ja) 悪夢障害の治療用医薬組成物
Krasuski Dr. Jack’s MedQuik Guide
EA049139B1 (ru) Лечение симптомов, вызванных менструальным циклом
HK40075517B (en) Treatment of menstrual cycle-induced symptoms
HK40075517A (en) Treatment of menstrual cycle-induced symptoms
KR20210135834A (ko) 헤스페리딘을 유효성분으로 함유하는 외상 후 스트레스장애 예방 또는 치료용 조성물
JPWO2014163152A1 (ja) ノンレム睡眠促進剤、深睡眠促進剤および自然睡眠誘発剤
EA021912B1 (ru) Способ профилактики и/или терапевтического лечения фибромиалгии

Legal Events

Date Code Title Description
FA Abandonment or withdrawal